Société TCR2 Therapeutics Inc.
Actions
TCRR
US87808K1060
Recherche biotechnologique et médicale
Métier
Nombre d'employés: 58
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
William Bertrand
PSD | President | 59 | 01/06/23 |
Robert Tighe
CTO | Chief Tech/Sci/R&D Officer | - | - |
Praveen Malhotra
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
Peter Olagunju
COO | Chief Operating Officer | - | 20/07/21 |
Carl F. Mauch
IRC | Investor Relations Contact | - | - |
Kevin Zikaras
PRN | Corporate Officer/Principal | - | 01/06/18 |
Richard Roomberg
AUD | Comptroller/Controller/Auditor | - | 01/01/19 |
Margaret Siegel
LAW | General Counsel | - | 01/01/18 |
Corporate Officer/Principal | 41 | 01/01/22 | |
Viera Muzithras
LAW | General Counsel | - | 27/05/20 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 39 261 745 | 38 342 495 ( 97,66 %) | 0 | 97,66 % |
Coordonnées société
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
+21,85% | 46,93 Md | |
+37,63% | 39,08 Md | |
-8,05% | 38,48 Md | |
+29,04% | 31,01 Md | |
-13,75% | 26,14 Md | |
+10,65% | 25,88 Md | |
+38,43% | 12,53 Md | |
-6,92% | 11,36 Md | |
-12,29% | 10,65 Md |